Sivik Global Healthcare LLC Has $4.88 Million Stock Position in Select Medical Holdings Co. (NYSE:SEM)

Sivik Global Healthcare LLC trimmed its position in shares of Select Medical Holdings Co. (NYSE:SEM) by 3.4% during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 140,000 shares of the health services provider’s stock after selling 5,000 shares during the quarter. Select Medical accounts for 2.1% of Sivik Global Healthcare LLC’s investment portfolio, making the stock its 23rd largest holding. Sivik Global Healthcare LLC owned 0.11% of Select Medical worth $4,882,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also bought and sold shares of the business. Tidal Investments LLC purchased a new stake in Select Medical in the 1st quarter valued at $467,000. UniSuper Management Pty Ltd bought a new stake in Select Medical in the 1st quarter valued at about $730,000. First Eagle Investment Management LLC raised its holdings in Select Medical by 14.8% during the 1st quarter. First Eagle Investment Management LLC now owns 275,559 shares of the health services provider’s stock valued at $8,308,000 after acquiring an additional 35,512 shares during the period. Hood River Capital Management LLC purchased a new stake in shares of Select Medical in the second quarter worth about $14,819,000. Finally, Comerica Bank grew its stake in Select Medical by 30.0% during the first quarter. Comerica Bank now owns 68,485 shares of the health services provider’s stock valued at $2,065,000 after acquiring an additional 15,824 shares in the last quarter. Institutional investors own 89.48% of the company’s stock.

Select Medical Trading Down 1.2 %

SEM stock traded down $0.46 during mid-day trading on Thursday, reaching $37.74. The company had a trading volume of 14,347 shares, compared to its average volume of 605,481. The company has a debt-to-equity ratio of 1.37, a current ratio of 1.13 and a quick ratio of 1.13. The firm has a 50 day moving average of $34.69 and a 200 day moving average of $34.64. The company has a market capitalization of $4.89 billion, a PE ratio of 17.86, a price-to-earnings-growth ratio of 2.04 and a beta of 1.42. Select Medical Holdings Co. has a 12 month low of $22.26 and a 12 month high of $40.98.

Select Medical (NYSE:SEM) last announced its quarterly earnings results on Thursday, October 31st. The health services provider reported $0.43 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.36 by $0.07. Select Medical had a net margin of 3.97% and a return on equity of 15.99%. The firm had revenue of $1.76 billion for the quarter, compared to the consensus estimate of $1.74 billion. During the same period in the prior year, the firm posted $0.46 earnings per share. The firm’s quarterly revenue was up 5.7% compared to the same quarter last year. On average, equities analysts predict that Select Medical Holdings Co. will post 2.16 earnings per share for the current fiscal year.

Select Medical Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, November 26th. Stockholders of record on Wednesday, November 13th will be given a dividend of $0.125 per share. This represents a $0.50 dividend on an annualized basis and a dividend yield of 1.32%. The ex-dividend date is Wednesday, November 13th. Select Medical’s dividend payout ratio (DPR) is currently 23.36%.

Wall Street Analyst Weigh In

Several research analysts have recently commented on SEM shares. Bank of America initiated coverage on Select Medical in a report on Tuesday, August 20th. They set a “buy” rating and a $42.00 price objective for the company. Royal Bank of Canada upped their price objective on shares of Select Medical from $40.00 to $47.00 and gave the company an “outperform” rating in a research note on Monday, November 4th. StockNews.com upgraded shares of Select Medical from a “hold” rating to a “buy” rating in a research report on Wednesday. Finally, Benchmark reiterated a “buy” rating and issued a $48.00 price objective on shares of Select Medical in a research report on Friday, November 1st. One equities research analyst has rated the stock with a hold rating and four have given a buy rating to the company. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $40.75.

About Select Medical

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.